A contract research organization (CRO) offers effective services to pharmaceutical and biotechnology organizations by reducing cost and time period required to conduct clinical trials. The U.S. continues to be one of the largest market for pharmaceutical research and development, thereby providing growth opportunities for contract research organizations (CROs). CROs offer drug discovery services such as drug target identification, drug discovery screening, library screening, fragment-based drug design, ligand-based drug design, ligand protein binding, drug profiling, lead identification, lead compound identification, and lead optimization. CROs conduct clinical trial studies (from phase I to phase IV). They are also engaged in medical coding, monitoring, clinical data management, protocol development, and other services which are included in clinical development of any drug molecules.
Market Dynamics
Rising number of U.S. Food and Drug Administration (FDA) approvals and clinical trials are supporting growth of biopharmaceutical industry and are expected to fuel growth of the U.S. contract research organization (CROs) market. The U.S. is expected to hold dominant position in the contract research organization market over the forecast period due to rising demand for generic drugs, increasing clinical research and development activities, and government support. The U.S. is one of the biggest market for contract research organization due increasing pharmaceutical research and development activities in the country, thereby providing growth opportunities for contract research organizations (CROs). For instance, according to the clinicaltrials.gov, as of September 12, 2022, the total number of registered clinical studies were 427,488 out of which 134,895 (32%) of the studies were performed in the U.S. alone.
Key features of the study:
- This report provides in-depth analysis of the U.S. Contract Research Organization (CROs) market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the U.S. Contract Research Organization (CROs) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Laboratory Corporation of America Holdings (Covance), IQVIA, Paraxel International Corporation, Syneos Health, PRA Health Sciences, Charles River Laboratoires International Inc. (CRL), Pharmaceutical Product Development (PPD), ICON Public Limited Corporation, Wuxi Apptec,Medpace Holdings, Inc,Medidata Solutions, Inc., Theorem Clinical Research, Pharmaron, Envigo, and Clinipace
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The U.S. Contract Research Organization (CROs) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. Contract Research Organization (CROs) market
Detailed Segmentation:
- U.S. Contract Research Organization (CROs) Market, By Service Type:
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb – IV
- Drug Development
- Medical Coding and Writing
- Monitoring
- Clinical Data Management
- Bio-statistics
- Site Management
- Protocol Development
- Biomarker Discovery
- U.S. Contract Research Organization (CROs) Market, By Therapeutic Application:
- Oncology
- Cardiovascular Diseases
- Central Nervous System Diseases
- Infectious Diseases
- Metabolic Disorders
- Immunological Disorders
- Respiratory Disorders
- Others
- U.S. Contract Research Organization (CROs) Market, By Size of CRO:
- Small size
- Medium size
- Large size
- Company Profiles
- Laboratory Corporation of America Holdings (Covance) *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IQVIA
- Paraxel International Corporation
- Syneos Health
- PRA Health Sciences
- Charles River Laboratoires International Inc. (CRL)
- Pharmaceutical Product Development (PPD)
- ICON Public Limited Corporation
- Wuxi Apptec
- Medpace Holdings, Inc
- Medidata Solutions, Inc.
- Theorem Clinical Research
- Pharmaron
- Envigo
- Clinipace
“*” marked represents similar segmentation in other categories in the respective section.
Infographics - Us Contract Research Organizations Market
